Cell interactions of the pancreatic cancer microenvironment (Homo sapiens)
From WikiPathways
Description
The molecular interactions of different cells in the pancreatic cancer tumor microenvironment (TME). Pancreatic cancer cells have developed various ways of evading and manipulating the immune system, and the TME plays an essential role in this. Various molecular interactions are involved in the interactions between cells in the TME. The pathway model is based on a review by Fan et al., 2020 (https://doi.org/10.1186/s12943-020-01151-3).
Quality Tags
Ontology Terms
Bibliography
View all... |
- Fan JQ, Wang MF, Chen HL, Shang D, Das JK, Song J; ''Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.''; Mol Cancer, 2020 PubMed Europe PMC Scholia
- Balachandran VP, Beatty GL, Dougan SK; ''Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.''; Gastroenterology, 2019 PubMed Europe PMC Scholia
- Andrews LP, Marciscano AE, Drake CG, Vignali DA; ''LAG3 (CD223) as a cancer immunotherapy target.''; Immunol Rev, 2017 PubMed Europe PMC Scholia
- Matkar PN, Singh KK, Rudenko D, Kim YJ, Kuliszewski MA, Prud'homme GJ, Hedley DW, Leong-Poi H; ''Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma.''; Oncotarget, 2016 PubMed Europe PMC Scholia
- Costache MI, Ioana M, Iordache S, Ene D, Costache CA, Săftoiu A; ''VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.''; Rom J Intern Med, 2015 PubMed Europe PMC Scholia
- Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A, Festa M, Guerriero L, Iorio V, Parente R, Pascale M, Marzullo L, Franco R, Arra C, Barbieri A, Rea D, Menichini G, Hahne M, Bijlsma M, Barcaroli D, Sala G, di Mola FF, di Sebastiano P, Todoric J, Antonucci L, Corvest V, Jawhari A, Firpo MA, Tuveson DA, Capunzo M, Karin M, De Laurenzi V, Turco MC; ''BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages.''; Nat Commun, 2015 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
CCL2 | GeneProduct | ENSG00000108691 (Ensembl) | |
CCL5 | GeneProduct | ENSG00000271503 (Ensembl) | |
CCR2 | GeneProduct | ENSG00000121807 (Ensembl) | |
CCR5 | GeneProduct | ENSG00000160791 (Ensembl) | |
CD80 | GeneProduct | ENSG00000121594 (Ensembl) | |
CD86 | GeneProduct | ENSG00000114013 (Ensembl) | |
CSF1 | GeneProduct | ENSG00000184371 (Ensembl) | |
CSF1R | GeneProduct | ENSG00000182578 (Ensembl) | |
CTLA4 | GeneProduct | ENSG00000163599 (Ensembl) | |
CXCL10 | GeneProduct | ENSG00000169245 (Ensembl) | |
CXCL12 | GeneProduct | ENSG00000107562 (Ensembl) | |
CXCR3 | GeneProduct | ENSG00000186810 (Ensembl) | |
CXCR4 | GeneProduct | ENSG00000121966 (Ensembl) | |
FAS | GeneProduct | ENSG00000026103 (Ensembl) | |
FASLG | GeneProduct | ENSG00000117560 (Ensembl) | |
HLA-DRA | GeneProduct | ENSG00000204287 (Ensembl) | |
HLA-DRB1 | GeneProduct | ENSG00000196126 (Ensembl) | |
Neuropilin-1 | GeneProduct | ENSG00000099250 (Ensembl) | |
TCR | GeneProduct | ||
TGFB1 | GeneProduct | ENSG00000105329 (Ensembl) | |
VEGFA | GeneProduct | ENSG00000112715 (Ensembl) | |
VEGFR2 | GeneProduct | ENSG00000128052 (Ensembl) | |
avβ6 | GeneProduct |
Annotated Interactions
No annotated interactions